Mercer, a global consulting leader in advancing health, wealth and career, and a wholly owned subsidiary of Marsh & McLennan Companies (NYSE: MMC), announced the appointment of Andrew Halpert as Clinical Innovation Leader, Health, US & Canada. In this role, he will be responsible for leading the strategy and execution of Mercer’s clinical consulting offerings and health strategy development. Dr. Halpert will report to Jean Moore, Specialty and Innovation Leader, US & Canada. He is based in San Francisco.
“We are thrilled to welcome Andrew to Mercer,” said Ms. Moore. “He is one of the most highly regarded and preeminent physicians in our industry. His experience in various healthcare consulting leadership roles will be a valuable addition to our team as we help clients strengthen and transform their health benefit and employee well-being programs.”
Dr. Halpert is a seasoned physician with 30 years of experience in the industry. Before joining Mercer, he was the Senior Director for Clinical and Network Solutions at Collective Health. Prior to that role, he was a Senior Physician Consultant at Willis Towers Watson. Dr. Halpert earned his Bachelors degree from Harvard University and his MD from University of California, San Francisco.
Mercer delivers advice and technology-driven solutions that help organizations meet the health, wealth and career needs of a changing workforce. Mercer’s more than 25,000 employees are based in 44 countries and the firm operates in over 130 countries. Mercer is a business of Marsh & McLennan Companies (NYSE: MMC), the world’s leading professional services firm in the areas of risk, strategy and people with 76,000 colleagues and annualized revenue approaching $17 billion. Through its market-leading businesses including Marsh, Guy Carpenter and Oliver Wyman, Marsh & McLennan helps clients navigate an increasingly dynamic and complex environment. For more information, visit www.mercer.com. Follow Mercer on Twitter @Mercer.